GoodCap’s team has more than three decades of research and clinical experience in plant and mycelial biotechnology, including more than fifteen years spent developing proprietary and stable plant genetics. We have collectively brought more than one hundred products to market and developed many exclusive formulations and techniques.
Our scientists have been recognized by federal regulatory bodies for our extensive work in controlled substances. We leverage state-of-the-art research facilities in Alberta, Canada to work at the forefront of drug development.
Through this work and our education, advocacy, and community building, we are poised to become a global leader in the legal cultivation, research, development, and commercialization of mushroom-related products.